Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3646334017 | Acalabrutinib in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3646335016 | Product containing acalabrutinib in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3646336015 | Product containing acalabrutinib in oral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3708316014 | Acalabrutinib-containing product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3708317017 | Product containing acalabrutinib in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acalabrutinib-containing product in oral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Acalabrutinib-containing product in oral dose form | Is a | Product manufactured as oral dose form | true | Inferred relationship | Some | ||
| Acalabrutinib-containing product in oral dose form | Is a | Acalabrutinib-containing product | true | Inferred relationship | Some | ||
| Acalabrutinib-containing product in oral dose form | Has active ingredient | Acalabrutinib | true | Inferred relationship | Some | 1 | |
| Acalabrutinib-containing product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Acalabrutinib only product in oral dose form | Is a | True | Acalabrutinib-containing product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR